thejoe
Teva Pharmaceuticals USA
Teva Pharmaceuticals USA: 196 FDA recall reports
Every drug recall the FDA has published for Teva Pharmaceuticals USA. The fault, and how the agency graded it.
196Reports
4Class I
22Ongoing
2022-02-09Most recent
4 Class I on this pageClass I means the FDA judged there was a reasonable probability of serious harm or death. Check the lot numbers against anything you hold.
What the classes mean
The FDA sorts every recall into one of three classes. The class is the whole story. It is also the part people skip.
Class II is the bulk of every list here. That matters. A long list of Class II says something different from one Class I.
By class
By year reported
Checking whether it affects you
The lot or code number is what matters. Not the product name. A recall covers
specific lots. Yours may not be one of them.
Check the code on your package against the report. The FDA keeps the current
list at fda.gov/safety/recalls.
The reports
The text below is quoted from the FDA record word for word.
Mimvey (estradiol and norethindrone acetate tablets USP) 1 mg/0.5 mg, packaged in cartons of 28 Tablets, Rx On
D-0522-2022 · Class III · reported 2022-02-09 · Terminated
- Why it was recalled
- Mislabeling
- Product
- Mimvey (estradiol and norethindrone acetate tablets USP) 1 mg/0.5 mg, packaged in cartons of 28 Tablets, Rx Only, Manufactured By: Barr Laboratories, Inc., Pomona, NY 10970, Manufactured For: Teva Pharmaceuticals USA Inc. North Wales, PA 19454, NDC 0093-5455-42
- Where it went
- USA Nationwide
- How much
- 6430 cartons
Mimvey (estradiol and norethindrone acetate tablets USP), 1 mg/0.5 mg, packaged in cartons of 28 Tablets, Rx o
D-0521-2022 · Class III · reported 2022-02-09 · Terminated
- Why it was recalled
- Mislabeling
- Product
- Mimvey (estradiol and norethindrone acetate tablets USP), 1 mg/0.5 mg, packaged in cartons of 28 Tablets, Rx only, Manufactured By: Barr Laboratories, Inc., Pomona, NY 10970, Manufactured For: Teva Pharmaceuticals USA Inc. North Wales, PA 19454, NDC 0093-5455-28
- Where it went
- USA Nationwide
- How much
- 218174 cartons
Doxylamine Succinate and Pyridoxine Hydrochloride Delayed-Release Tablets 10 mg/10 mg, 100-count bottle, Rx On
D-0461-2022 · Class II · reported 2022-02-09 · Terminated
- Why it was recalled
- Failed Dissolution Specification: Dissolution results are below specification limits for the active ingredient
- Product
- Doxylamine Succinate and Pyridoxine Hydrochloride Delayed-Release Tablets 10 mg/10 mg, 100-count bottle, Rx Only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314, USA, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 007045 USA, NDC 0591-2132-01
- Where it went
- Nationwide in the USA
- How much
- 6205 100-count bottles
Tretinoin Capsules, 10 mg, 100 count bottle, Rx Only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, N
D-0520-2022 · Class II · reported 2022-02-09 · Terminated
- Why it was recalled
- Failed Dissolution Specifications; Low Out of specification (OOS) results for dissolution.
- Product
- Tretinoin Capsules, 10 mg, 100 count bottle, Rx Only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0555-0808-02
- Where it went
- nationwide in the USA
- How much
- 1,175 Bottles
Brinzolamide Ophthalmic Suspension, USP 1%, packaged as a)10 ml dropper bottles (NDC 0591-2127-79), and b) 15
D-0373-2022 · Class II · reported 2022-01-26 · Terminated
- Why it was recalled
- Defective Container: The notch in the cap that fits into the nozzle of the dropper could break off and block the dropper possibly resulting in the product not dispensing.
- Product
- Brinzolamide Ophthalmic Suspension, USP 1%, packaged as a)10 ml dropper bottles (NDC 0591-2127-79), and b) 15 ml dropper bottles (NDC 0591-2127-12), Rx Only, Manufactured in India By: Indoco Remedies Limited Verna, Goa - 403722, India, Manufactured For: Teva Pharmaceuticals USA, Inc. Parsippany, NJ
- Where it went
- Nationwide in the USA
- How much
- a) 66,099 dropper bottles; b) 21,243 dropper bottles
MethylPREDNISolone Acetate Injectable Suspension USP 400 mg/10mL (40mg/mL), 10 mL Multiple-Dose Vial, Rx Only,
D-0370-2022 · Class II · reported 2022-01-19 · Terminated
- Why it was recalled
- Lack of Assurance of Sterility
- Product
- MethylPREDNISolone Acetate Injectable Suspension USP 400 mg/10mL (40mg/mL), 10 mL Multiple-Dose Vial, Rx Only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured By: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 16714-090-01, packaged in cartons.
- Where it went
- Methylprednisolone, TN Norepinephrine BItartrate - MS, OH
- How much
- 7,400 cartons
Norepinephrine Bitartrate Injection USP 4 mg/4 mL (1 mg/mL), 4 mL Single-Dose Vials, 10 vials per carton, Rx O
D-0371-2022 · Class II · reported 2022-01-19 · Terminated
- Why it was recalled
- Lack of Assurance of Sterility
- Product
- Norepinephrine Bitartrate Injection USP 4 mg/4 mL (1 mg/mL), 4 mL Single-Dose Vials, 10 vials per carton, Rx Only, Manufactured By: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 0703-1153-03.
- Where it went
- Methylprednisolone, TN Norepinephrine BItartrate - MS, OH
- How much
- 11,450 vials
Penicillin V Potassium for Oral Solution, USP 125 mg (200,000 U) per 5 mL a) 100 mL (NDC 00093-4125-73) and b)
D-0294-2022 · Class II · reported 2021-12-29 · Terminated
- Why it was recalled
- Subpotent
- Product
- Penicillin V Potassium for Oral Solution, USP 125 mg (200,000 U) per 5 mL a) 100 mL (NDC 00093-4125-73) and b) 200 mL (NDC 00093-4125-74) (when mixed) bottles, Rx Only, Manufactured For: Teva Pharmaceuticals USA, Inc. North Wales, PA 19454
- Where it went
- nationwide
- How much
- a) 86,790 and b) 25,416 bottles
Cartia XT (Diltiazem Hydrochloride Extended-Release Capsules, USP) 120 mg, Rx Only, 90 capsules, labelled as (
D-0232-2022 · Class II · reported 2021-11-24 · Terminated
- Why it was recalled
- Labelling: Incorrect Exp. Date
- Product
- Cartia XT (Diltiazem Hydrochloride Extended-Release Capsules, USP) 120 mg, Rx Only, 90 capsules, labelled as (a) Manufactured By: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054; (b) Manufactured By: Actavis Laboratories FL. Inc, Fort Lauderdale FL. 33314 USA, Distributed by Avista Pharma Inc. Parsippany, NJ 07054 USA. NDC 62037-597-90
- Where it went
- Distributed Nationwide in the USA
- How much
- 32316 bottles
Clonidine Transdermal System, USP 0.1 mg/day, 4 patches per carton, Rx only, Manufactured by: Actavis Laborato
D-0235-2022 · Class III · reported 2021-11-24 · Terminated
- Why it was recalled
- Failed Impurities/Degradation Specifications
- Product
- Clonidine Transdermal System, USP 0.1 mg/day, 4 patches per carton, Rx only, Manufactured by: Actavis Laboratories, UT Inc., Salt Lake City, UT, Distributed by: Actavis Pharma, Inc., Parsippany, NJ NDC 0591-3508-04
- Where it went
- Nationwide and Puerto Rico
- How much
- 64,978 patches
AirDuo Digihaler 55/14 (fluticasone propionate 55 mcg and salmeterol 14 mcg) Inhalation Powder, Rx Only, Mktd
D-0023-2022 · Class II · reported 2021-10-27 · Terminated
- Why it was recalled
- Subpotent drug: OOS results of Label Claimed Emitted Dose for salmeterol
- Product
- AirDuo Digihaler 55/14 (fluticasone propionate 55 mcg and salmeterol 14 mcg) Inhalation Powder, Rx Only, Mktd by: Teva Respiratory, LLC Frazer, PA 19355, Manufactured in Ireland, NDC 59310-111-06
- Where it went
- USA Nationwide
- How much
- 1,978 inhalers
AirDuo Digihaler 232/14 (fluticasone propionate 232 mcg and salmeterol 14 mcg) Inhalation Powder, Sample Not F
D-0022-2022 · Class II · reported 2021-10-27 · Terminated
- Why it was recalled
- Subpotent drug: OOS results of Label Claimed Emitted Dose for salmeterol
- Product
- AirDuo Digihaler 232/14 (fluticasone propionate 232 mcg and salmeterol 14 mcg) Inhalation Powder, Sample Not For Sale, Rx Only, Mktd by: Teva Respiratory, LLC, Frazer, PA 19355, Manufactured in Ireland, NDC 59310-530-08.
- Where it went
- USA Nationwide
- How much
- 3,240 inhalers
AirDuo Digihaler 113/14 (fluticasone propionate 113 mcg and salmeterol 14 mcg) Inhalation Powder, Rx Only, Mkt
D-0024-2022 · Class II · reported 2021-10-27 · Terminated
- Why it was recalled
- Subpotent drug: OOS results of Label Claimed Emitted Dose for salmeterol
- Product
- AirDuo Digihaler 113/14 (fluticasone propionate 113 mcg and salmeterol 14 mcg) Inhalation Powder, Rx Only, Mktd. by: Teva Respiratory, LLC, Frazer, PA 19355, Manufactured in Ireland, NDC 59310-129-06.
- Where it went
- USA Nationwide
- How much
- 4,850 inhalers
AirDuo Digihaler 232/14 (fluticasone propionate 232 mcg and salmeterol 14 mcg) Inhalation Powder, Rx Only, Mkt
D-0025-2022 · Class II · reported 2021-10-27 · Terminated
- Why it was recalled
- Subpotent drug: OOS results of Label Claimed Emitted Dose for salmeterol
- Product
- AirDuo Digihaler 232/14 (fluticasone propionate 232 mcg and salmeterol 14 mcg) Inhalation Powder, Rx Only, Mktd by: Teva Respiratory, LLC, Frazer, PA 19355, Manufactured in Ireland, NDC 59310-136-06
- Where it went
- USA Nationwide
- How much
- 5,500 inhalers
AirDuo Digihaler 113/14 (fluticasone propionate 113 mcg and salmeterol 14 mcg) Inhalation Powder, Sample Not F
D-0021-2022 · Class II · reported 2021-10-27 · Terminated
- Why it was recalled
- Subpotent drug: OOS results of Label Claimed Emitted Dose for salmeterol
- Product
- AirDuo Digihaler 113/14 (fluticasone propionate 113 mcg and salmeterol 14 mcg) Inhalation Powder, Sample Not For Sale, Rx Only, Mktd by: Teva Respiratory, LLC , Frazer, PA 19355, Manufactured in Ireland, NDC 59310-520-08
- Where it went
- USA Nationwide
- How much
- 10,665 inhalers
Cyclobenzaprine Hydrochloride Tablets, 7.5mg, 100 count tablets per bottle, Rx Only, Manufactured by: Actavis
D-0775-2021 · Class II · reported 2021-09-08 · Terminated
- Why it was recalled
- CGMP Deviations: Out of specification (OOS) test result for Total Aerobic Microbial Count (TAMC) and Total Yeast and Mold Count (TYMC) for an excipient batch of Dibasic Calcium Phosphate.
- Product
- Cyclobenzaprine Hydrochloride Tablets, 7.5mg, 100 count tablets per bottle, Rx Only, Manufactured by: Actavis Laboratories FL, Inc. Fort Lauderdale, FL 33314, NDC 70199-014-01
- Where it went
- Product was distributed nationwide.
- How much
- 4,587 bottles
Cyclobenzaprine Hydrochloride Tablets, 7.5mg, 100 count tablets per bottle, Rx Only, Manufactured by: Actavis
D-0776-2021 · Class II · reported 2021-09-08 · Terminated
- Why it was recalled
- CGMP Deviations: Out of specification (OOS) test result for Total Aerobic Microbial Count (TAMC) and Total Yeast and Mold Count (TYMC) for an excipient batch of Dibasic Calcium Phosphate.
- Product
- Cyclobenzaprine Hydrochloride Tablets, 7.5mg, 100 count tablets per bottle, Rx Only, Manufactured by: Actavis Laboratories FL, Inc. Fort Lauderdale, FL 33314, NDC 57237-266-01
- Where it went
- Product was distributed nationwide.
- How much
- 4,992 bottles
Cyclobenzaprine Hydrochloride Tablets, 7.5mg, 100 count tablets per bottle, Rx Only, Manufactured by: Actavis
D-0774-2021 · Class II · reported 2021-09-08 · Terminated
- Why it was recalled
- CGMP Deviations: Out of specification (OOS) test result for Total Aerobic Microbial Count (TAMC) and Total Yeast and Mold Count (TYMC) for an excipient batch of Dibasic Calcium Phosphate.
- Product
- Cyclobenzaprine Hydrochloride Tablets, 7.5mg, 100 count tablets per bottle, Rx Only, Manufactured by: Actavis Laboratories FL, Inc. Fort Lauderdale, FL 33314, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, NDC 0591-3330-01
- Where it went
- Product was distributed nationwide.
- How much
- 9,655 bottles
Epoprostenol Sodium for Injection, 1.5 mg/vial, 10 mL vials, Rx only, Teva Pharmaceuticals USA, Inc. North Wal
D-0738-2021 · Class II · reported 2021-08-25 · Terminated
- Why it was recalled
- Lack of Assurance of Sterility
- Product
- Epoprostenol Sodium for Injection, 1.5 mg/vial, 10 mL vials, Rx only, Teva Pharmaceuticals USA, Inc. North Wales, PA 19454, NDC 0703-1995-01
- Where it went
- Product was distributed Nationwide, including Puerto Rico.
- How much
- 12,698 vials
DAUNOrubicin Hydrochloride Injection 20 mg/4mL, 4mL Single Dose vials, 10 in 1 carton, Rx only, Teva Parentera
D-0730-2021 · Class II · reported 2021-08-25 · Terminated
- Why it was recalled
- Lack of Assurance of Sterility
- Product
- DAUNOrubicin Hydrochloride Injection 20 mg/4mL, 4mL Single Dose vials, 10 in 1 carton, Rx only, Teva Parenteral Medicines, Inc. Irvine, CA 92618 Vial NDC# 0703-5233-11, Carton NDC # 0703-5233-13
- Where it went
- Product was distributed Nationwide, including Puerto Rico.
- How much
- 1,351 vials
Leucovorin Calcium for Injection, USP 350 mg/vial, 17.5 mL single-use vials, Rx only, Teva Parenteral Medicine
D-0737-2021 · Class II · reported 2021-08-25 · Terminated
- Why it was recalled
- Lack of Assurance of Sterility
- Product
- Leucovorin Calcium for Injection, USP 350 mg/vial, 17.5 mL single-use vials, Rx only, Teva Parenteral Medicines, Inc. Irvine, CA 92618, NDC 0703-5145-01
- Where it went
- Product was distributed Nationwide, including Puerto Rico.
- How much
- 434,229 vials
Methylprednisolone Acetate Injectable Suspension USP, 40 mg/mL, packaged in a) 1 mL Single-Dose vials (0703-00
D-0731-2021 · Class II · reported 2021-08-25 · Terminated
- Why it was recalled
- Lack of Assurance of Sterility
- Product
- Methylprednisolone Acetate Injectable Suspension USP, 40 mg/mL, packaged in a) 1 mL Single-Dose vials (0703-0031-01), and b) 5mL Multi Dose Vials (NDC 0703-0043-01), and c) 10 mL Multi-Dose Vials (NDC 0703-0045-01), Rx only, TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454.
- Where it went
- Product was distributed Nationwide, including Puerto Rico.
- How much
- 193,845 vials
Norepinephrine Bitartrate Injection, USP 4 mg/4 mL, 4 mL single dose vials, packaged in 10 vial cartons (NDC 0
D-0739-2021 · Class II · reported 2021-08-25 · Terminated
- Why it was recalled
- Lack of Assurance of Sterility
- Product
- Norepinephrine Bitartrate Injection, USP 4 mg/4 mL, 4 mL single dose vials, packaged in 10 vial cartons (NDC 0703-1153-03) Rx only, Teva Pharmaceuticals USA Inc. North Wales, PA 19454, vial NDC 0703-1153-01
- Where it went
- Product was distributed Nationwide, including Puerto Rico.
- How much
- 34,100 vials
Octreotide Acetate Injection 1000 mcg/5mL, 5 mL multi-dose vial, Rx only, Teva Pharmaceuticals USA. Inc. North
D-0736-2021 · Class II · reported 2021-08-25 · Terminated
- Why it was recalled
- Lack of Assurance of Sterility
- Product
- Octreotide Acetate Injection 1000 mcg/5mL, 5 mL multi-dose vial, Rx only, Teva Pharmaceuticals USA. Inc. North Wales, PA 19454, NDC 0703-3333-01
- Where it went
- Product was distributed Nationwide, including Puerto Rico.
- How much
- 16,644 vials
Methylprednisolone Acetate Injectable Suspension USP, 80 mg/mL, packaged in a) 1 mL Single-Dose vials (0703-00
D-0743-2021 · Class II · reported 2021-08-25 · Terminated
- Why it was recalled
- Lack of Assurance of Sterility
- Product
- Methylprednisolone Acetate Injectable Suspension USP, 80 mg/mL, packaged in a) 1 mL Single-Dose vials (0703-0051-01), and b) 5mL Multi Dose Vials (NDC 0703-0063-01), Rx only, TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454.
- Where it went
- Product was distributed Nationwide, including Puerto Rico.
- How much
- 50,713 vials
Idarubicin Hydrochloride Injection 20 mg/20 mL, 20 mL single-dose vial, Rx only, Teva Pharmaceuticals USA, Inc
D-0734-2021 · Class II · reported 2021-08-25 · Terminated
- Why it was recalled
- Lack of Assurance of Sterility
- Product
- Idarubicin Hydrochloride Injection 20 mg/20 mL, 20 mL single-dose vial, Rx only, Teva Pharmaceuticals USA, Inc. North Wales, PA 19454, NDC 0703-4156-11
- Where it went
- Product was distributed Nationwide, including Puerto Rico.
- How much
- 2,091 vials
Leucovorin Calcium for Injection, USP 350 mg/vial, 17.5 mL single-use vials, Rx only, Manufactured by: Teva Ph
D-0747-2021 · Class II · reported 2021-08-25 · Terminated
- Why it was recalled
- Lack of Assurance of Sterility
- Product
- Leucovorin Calcium for Injection, USP 350 mg/vial, 17.5 mL single-use vials, Rx only, Manufactured by: Teva Pharmaceuticals USA, Inc. North Wales, PA 19454, NDC 0703-5145-91
- Where it went
- Product was distributed Nationwide, including Puerto Rico.
- How much
- 42,046 vials
Octreotide Acetate Injection 100 mcg/mL, 1 mL single-dose vial, Rx only, Teva Pharmaceuticals USA. Inc. North
D-0744-2021 · Class II · reported 2021-08-25 · Terminated
- Why it was recalled
- Lack of Assurance of Sterility
- Product
- Octreotide Acetate Injection 100 mcg/mL, 1 mL single-dose vial, Rx only, Teva Pharmaceuticals USA. Inc. North Wales, PA 19454, NDC 0703-3311-01
- Where it went
- Product was distributed Nationwide, including Puerto Rico.
- How much
- 3,067 vials
Octreotide Acetate Injection 50 mcg/mL, 1 mL single-dose vial, Rx only, Teva Pharmaceuticals USA. Inc. North W
D-0745-2021 · Class II · reported 2021-08-25 · Terminated
- Why it was recalled
- Lack of Assurance of Sterility
- Product
- Octreotide Acetate Injection 50 mcg/mL, 1 mL single-dose vial, Rx only, Teva Pharmaceuticals USA. Inc. North Wales, PA 19454, NDC 0703-3301-01
- Where it went
- Product was distributed Nationwide, including Puerto Rico.
- How much
- 6,184 vials
Haloperidol Decanoate Injection 100 mg/mL, packaged in a) 1 mL single-dose vials (NDC 0703-7131-01), b) 5 mL m
D-0732-2021 · Class II · reported 2021-08-25 · Terminated
- Why it was recalled
- Lack of Assurance of Sterility
- Product
- Haloperidol Decanoate Injection 100 mg/mL, packaged in a) 1 mL single-dose vials (NDC 0703-7131-01), b) 5 mL multi-dose vials (NDC 0703-7133-01), Rx only, Teva Pharmaceuticals USA, Inc. North Wales, PA 19454.
- Where it went
- Product was distributed Nationwide, including Puerto Rico.
- How much
- 16,226 vials
Showing the 30 most recent of 196. The rest are searchable at the FDA enforcement report database.
Read these counts with three things in mind
A firm with more recalls usually makes more products. A contract packer runs
hundreds of lines. It will out-recall a company with one product whatever either
does. This is not a safety ranking.
Most recalls here are voluntary. A firm found its own fault and pulled the stock.
That is the system working. It lands in this database looking the same as a recall
the FDA had to push for.
Terminated means the FDA considers the recall finished. It is not a verdict.
It does not mean anyone was harmed.
Source: openFDA enforcement reports, retrieved 2026-08-05. FDA dataset last updated 2026-07-29.
← All drug recalls